comparemela.com

Latest Breaking News On - Joseph goldstein - Page 4 : comparemela.com

How an experimental drug reverses fatty liver disease

A drug in clinical trials as a treatment for metabolic dysfunction-associated steatotic liver disease (MASLD) works with a one-two punch that shuts down triglyc

Marietta Council Tightens New Restrictions on Downtown Housing

Marietta Council OKs New Restrictions on Downtown Housing

Regeneron Pharmaceuticals Inc Director Joseph Goldstein Sells 2,707 Shares

Joseph Goldstein, Director at Regeneron Pharmaceuticals Inc (NASDAQ:REGN), sold 2,707 shares of the company on January 23, 2024, according to a recent SEC Filing.

Statins vs kidney disease death risk: Cholesterol-lowering drugs help

New research looking at data from United States veterans has found a link between a lower death risk in chronic kidney disease and taking prescription statins, a type of cholesterol-lowering drugs.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.